4//SEC Filing
Glover Eddie Wabern 4
Accession 0001387131-18-000788
CIK 0000887247other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:06 PM ET
Size
5.5 KB
Accession
0001387131-18-000788
Insider Transaction Report
Form 4
Glover Eddie Wabern
CEO of U.S. Compounding, Inc.
Transactions
- Award
Employee Stock Option (right to buy)
2018-02-21+35,000→ 35,000 totalExercise: $2.83Exp: 2028-02-21→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the grant date.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
Related Parties
1- filerCIK 0001671547
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 6:06 PM ET
- Size
- 5.5 KB